The correlation between clinical and CT findings in cerebral tumours was prospectively studied in 1191 consecutive referrals for cerebral CT. CT revealed a mass lesion in 51 cases (4 3%): 32 neoplasms, five haematomas and one abscess. The diagnostic specificity of CT for neoplasmic tumours was 86% (32 of 37 
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When MRI is not available CT is the method of choice for investigation of 
Patients and methods
We studied all adult neurological patients who over a 12 month period were investigated by cranial CT at Oulu University Central Hospital which supplies neurological services for an adult population of 280 000. There were 1191 cranial CT investigations (572 men and 619 women), and the patients' ages ranged from 15 to 87 years, mean 46 years. One fifth were investigated as emergencies the remaining were elective.
The decision to refer a patient for CT was always based on careful neurological examination. The clinician recorded the case history, symptoms and signs and suggested the anatomical site and nature of the CNS lesion. The main aetiological categories were: tumour, ischaemia, haemorrhage, degenerative CNS disease, malformation, hydrocephalus and trauma. The anatomical sites for suggested lesion were: cerebral hemisphere, posterior fossa or brain stem, other specified, generalised and undefined.
Two CT units were available (Somatom 2 and Toshiba TCT 80A). Axial scans were obtained, complemented by coronal sections when necessary. The slice thickness was 4-5 mm in the posterior fossa and 8-10 mm at the upper levels of the brain. The findings were analysed by a neuroradiologist; radiological diagnosis, localisation of the lesion and the use of contrast enhancement were recorded. The decision to use contrast medium was made by the neuroradiologist after reviewing the unenhanced images and the clinical history. Enhancement (a 50 ml intravenous bolus of 60-70% ionic iodine) was used in 537 cases (45%).
The cases of verified IC tumours were manually analysed in detail and BMDP Statistical Software (University of California, 1985) was used in the treatment of the data.
Results
CT revealed 51 mass lesions in the 1 91 patients. These proved to be a neoplasm in 32 cases, a haematoma in four, and an abscess in one (table) . The remaining 14 cases were follow up examinations of previously diagnosed IC tumours.
The 32 IC tumours consisted of astrocytomas (14) , metastases (7), meningiomas (5), glioblastomas (3), tumours of unspecific pathology (1), hemangioblastoma (1) and meningeal melanoma (1). Histological confirmation was obtained in 26 cases (81%). Biopsy or operation was withheld in six cases, in which the presumed diagnosis was based on CT and angiography (case 18), or the presence of a Sotaniemi, Rantala, Pyhtinen, Myllyla findings were normal but the history suggested a tumour. This emphasises the importance of a careful history and examination. Overall, the clinician's localisation of the tumour was correct in 63% of cases. Sellar, parasagittal and frontal tumours posed problems and failure of localisation was most common in patients with symptoms and signs of increased IC pressure as the only manifestations of the disease.
The correlation between the size of the tumour and clinical localisation proved weak. A large tumour was often found to cause nonfocal disturbances, as might be expected in slowly growing tumours. This indeed became evident when the correlation between histology and clinical localisation was analysed. Meningiomas were localised less successively than invasive parenchymal tumours but were associated with a considerably longer symptomatic period. Seven tumours were not diagnosed clinically.
The criteria for cranial CT should not be too strict. The previously reported prevalence of IC tumours as the cause of epilepsy in adult patients has varied from 4% to 38%." 1314 One CT study" of 148 patients after their first seizure revealed nine (6%) with a tumour, which agrees with our results.
Investigation of patients with headache but without neurological signs was not fruitful. Two patients (1%) were found to have an IC tumour: a relapsing frontal astrocytoma, and a parasellar metastasis associated with a one year history of headache, in none of the others did the CT findings change treatment. Our findings support previous conclusions9 012 concerning the absence of correlation between headache as an isolated symptom and abnormal CT findings. In one study of 505 patients with headache as their sole symptom and normal findings in a complete neurological examination, cerebral CT revealed a tumour in 13 (3%) and some other abnormality in a further 25 (5%).10 Thus the cost effectiveness of CT in investigating patients with headache and normal neurological findings is low. On the other hand, exclusion of a mass lesion is often necessary, perhaps by means of an abbreviated CT examination, as has been suggested previously.'0
Where there is a continuing disproportion between the supply of and demand for cranial CT, a careful clinical examination remains necessary for adequate patient selection. CT is, however, often required for exclusion ofa space occupying lesion, to make therapeutic decisions possible. When the symptoms and signs remain unexplained after CT and ancillary investigations, clinical follow up is needed. CT has not completely solved the differential diagnostic problems, for example, of distinguishing between infarcts and low grade astrocytomas and therefore clinical follow up is needed when symptoms and signs remain unexplained after CT and ancillary investigations. The ever growing demand for imaging investigations of the CNS can only be met by careful clinical selection of patients.
